Clinical trial Recruiting at 2 sites Interventional

Robotic-assisted versus conventional bronchoscopy for cryobiopsy to diagnose interstitial lung disease

Official title: Robotic-Assisted Versus Conventional Bronchoscopy for Cryobiopsy in the Diagnosis of Interstitial Lung Disease: A Randomized Controlled Trial

Run by University of Zurich · NCT07500818 · Data updated 2026-11-12

This trial will test whether robotic-assisted bronchoscopy with cone-beam CT finds better biopsy samples than conventional fluoroscopy-guided bronchoscopy in adults who need a lung biopsy for suspected interstitial lung disease.

Quick facts

Study typeInterventional
SexAll
Enrollment30 (estimated)
SponsorUniversity of Zurich
Academic / other
Locations2 sites (Lucerne, Canton of Lucerne and 1 other locations)
StatusRecruiting
StartedFebruary 1, 2026
Main results expectedFebruary 1, 2027
Study endsSeptember 1, 2027
Registry record updatedMarch 30, 2026
Trial IDNCT07500818 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (age ≥18) with suspected interstitial lung disease who have a non-diagnostic or indeterminate HRCT pattern and are medically eligible for transbronchial lung cryobiopsy are ideal candidates.

Probably not a fit

Patients with a definite UIP pattern on HRCT, severe pulmonary hypertension, severe hypoxemia, coagulopathy, pregnancy, or other contraindications to bronchoscopy are unlikely to benefit from enrollment.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter randomized trial assigns patients 1:1 to either conventional bronchoscopy with fluoroscopy-guided transbronchial lung cryobiopsy or robotic-assisted bronchoscopy with cone-beam CT guidance. In both arms four biopsies will be taken from two different lobes using a 1.7 mm cryoprobe. Biopsy location with RAB+CBCT allows real-time confirmation of sampling, while the conventional arm relies on 2D fluoroscopy for navigation. Histological specimens will be reviewed by a blinded multidisciplinary ILD board to determine diagnostic yield.

Why it matters

Potential benefit: If successful, robotic-assisted bronchoscopy with CBCT could increase the rate of definitive histologic diagnoses and reduce the need for surgical lung biopsy.

How similar studies have gone: Observational and feasibility studies suggest improved navigation and sampling with robotic bronchoscopy and CBCT, but randomized controlled data directly comparing this approach to fluoroscopy-guided cryobiopsy are not yet available.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥18 years
* Clinical suspicion of interstitial lung disease requiring histological confirmation
* Non-diagnostic HRCT pattern (e.g. probable UIP or indeterminate pattern)
* Candidate for transbronchial lung cryobiopsy
* Ability to provide informed consent

Exclusion Criteria:

* Definite UIP pattern on HRCT
* Severe pulmonary hypertension
* Severe hypoxemia contraindicating bronchoscopy
* Coagulopathy or contraindication to biopsy
* Pregnancy
* Inability to provide informed consent

Where it's running

  • Cantonal Hospital of Lucerne
    Lucerne, Canton of Lucerne, Switzerland
    Recruiting
  • University Hospital Zurich
    Zurich, Canton of Zurich, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.